CDK6 and nasopharyngeal carcinoma: Previous studies have revealed that CDK6 enhances radioresistance in human malignancies including nasopharyngeal cancer and HPV negative head and neck squamous cell carcinoma possibly by promoting RAD51 and BRCA1 expression and thereby activating homologous recombinational (HR) DNA repair after IR (21, 22).